UK markets close in 6 hours 46 minutes
  • FTSE 100

    6,953.07
    -72.36 (-1.03%)
     
  • FTSE 250

    22,755.34
    -177.85 (-0.78%)
     
  • AIM

    1,226.62
    -7.06 (-0.57%)
     
  • GBP/EUR

    1.1707
    +0.0002 (+0.02%)
     
  • GBP/USD

    1.3784
    -0.0039 (-0.29%)
     
  • BTC-GBP

    27,030.23
    -611.12 (-2.21%)
     
  • CMC Crypto 200

    882.80
    -32.69 (-3.57%)
     
  • S&P 500

    4,422.30
    +10.51 (+0.24%)
     
  • DOW

    35,144.31
    +82.76 (+0.24%)
     
  • CRUDE OIL

    72.01
    +0.10 (+0.14%)
     
  • GOLD FUTURES

    1,795.80
    -3.40 (-0.19%)
     
  • NIKKEI 225

    27,970.22
    +136.93 (+0.49%)
     
  • HANG SENG

    25,086.43
    -1,105.89 (-4.22%)
     
  • DAX

    15,451.48
    -167.50 (-1.07%)
     
  • CAC 40

    6,524.86
    -53.74 (-0.82%)
     

Global Bioresorbable Stents Market to Reach $691.6 Million by 2027

·10-min read

Abstract: - Global Bioresorbable Stents Market to Reach $691. 6 Million by 2027. - Amid the COVID-19 crisis, the global market for Bioresorbable Stents estimated at US$316.

New York, June 24, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Bioresorbable Stents Industry" - https://www.reportlinker.com/p05956093/?utm_source=GNW
7 Million in the year 2020, is projected to reach a revised size of US$691.6 Million by 2027, growing at a CAGR of 11% over the analysis period 2021-2027. Polymer-based Bioresorbable Stents, one of the segments analyzed in the report, is projected to reach US$499.5 Million by the end of the analysis period. After a thorough analysis of the business implications of the pandemic and its induced economic crisis, growth in the Metal-based Bioresorbable Stents segment is readjusted to a revised 10% CAGR for the next 7-year period.

European Market is Estimated at $170.6 Million, While Asia-Pacific is Forecast to Grow at 10.3% CAGR

- Bioresorbable Stents market in Europe is estimated at US$170.6 Million in the year 2020. Asia-Pacific is forecast to reach a projected market size of US$176.2 Million by the year 2027 trailing a CAGR of 10.3% over the analysis period 2020 to 2027. Rest of World is forecast to grow at 11.1% over the 2020-2027 period.
Select Competitors (Total 25 Featured)

  • Abbott Laboratories

  • Amaranth Medical, Inc.

  • Arterial Remodeling Technologies SA

  • Arterius Ltd.

  • Biotronik SE & Co. KG

  • Boston Scientific Corporation

  • Elixir Medical Corporation

  • Kyoto Medical Planning Co., Ltd.

  • Lepu Medical Technology (Beijing) Co., Ltd.

  • Meril Life Sciences Pvt., Ltd.

  • OrbusNeich

  • Qualimed

  • Reva Medical, Inc.

  • S3V Vascular Technologies Pvt., Ltd.




Read the full report: https://www.reportlinker.com/p05956093/?utm_source=GNW

CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
Coronary Artery Disease (CAD) - A Perspective
Causes and Symptoms
Treatment Options for Coronary Artery Disease
Percutaneous Coronary Intervention (PCI)
Coronary Stenting
Types of Coronary Stents
Bare Metal Stents (BMS)
Drug Eluting Stents (DES)
Bioresorbable Stents/Scaffolds
Design and Composition of Bioresorbable Stents
Different Types of Bioresorbable Stents
Metallic Bioresorbable Stents
Polymer Bioresorbable Stents
Degradation Period of Select Bioabsorbable Materials
Challenges
Clinical Characteristics of Various Coronary Stents
Other Treatment Options for Coronary Heart Disease
Coronary Artery Bypass Grafting (CABG)
Minimally Invasive Direct Coronary Artery Bypass (MIDCAB)
TransMyocardial Laser Revascularization (TMR)
Peripheral Arterial Disease: Understanding the Stealthy Peril
Treatment for PAD
Stenting- A Treatment Option for PAD
BioResorbable Stents - A Prelude
Bioresorbable Vascular Stents: Advantages and Challenges
Bioresorbable Stents - A Revolutionary Technology, Riddled with
Controversies
Abbott Stops Sales of the Once Promising ?Absorb? Bioresorbable
Stents due to Adverse Events
Impact of Abbott?s Withdrawal of Absorb on the Bioresorbable
Stent Industry
Impact of Covid-19 and a Looming Global Recession
2020 Marked as a Year of Disruption & Transformation
EXHIBIT 1: World Economic Growth Projections (Real GDP, Annual
% Change) for 2020 through 2022
Impact of COVID - 19 on Coronary Stents Market
Impact on Supply Chain
Impact of COVID-19 Outbreak on Elective Surgeries
Global Bioresorbable Stents Market Buckles under COVID-19 Strain
GLOBAL MARKET OVERVIEW
Global Bioresorbable Stents Set to Witness Growth in Future
Europe Dominates, Asia-Pacific Exhibits Fastest Growth
CAD Constitutes the Leading Application
Metallic Vs. Polymer-based Stents
Bioabsorbable Metallic Stents
Bioabsorbable Polymer Stents
Disappointing Results by Absorb to Increase Focus on Metallic
Stents
Availability of Alternative Treatments - Hindrance to Market
Growth
Market Challenges
MARKET OUTLOOK
Bioresorbable and Integrated Biosensor Technology to Redefine
Future of Vascular Stents
The Future of BRS Technology
COMPETITION
Select Approved Bioresorbable Scaffolds
Select Bioresorbable Stents in Pipeline
Abbott Revives Bioresorbable Stent Clinical Trials to Evaluate
New Esprit Scaffold
Recent Market Activity

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS
Polymeric Resorbable Scaffolds Hold a Major Market Share
The Absorb BRS program
Desaminotyrosine Polycarbonate-based BRS
The FANTOM program
Magnesium-based BRS
The Magmaris program
Iron-based BRS
Global Menace of Coronary Artery Disease (CAD) - A Major Growth
Driver
EXHIBIT 2: Global Annual Medical Cost of CVD in the United
States: 2015-2030
EXHIBIT 3: Fatalities by Heart Conditions - Estimated
Percentage Breakdown for Cardiovascular Disease, Ischemic
Heart Disease, Stroke, and Others
Ageing Demographics and Longer Life Expectancy Bolsters Market
Growth
EXHIBIT 4: Global Population Statistics for the 65+ Age Group
in Million by Geographic Region for the Years 2019, 2025, 2035
and 2050
EXHIBIT 5: Elderly Population (65+ Years) as a % of Total
Population by Developed, Less Developed and Least Developed
Regions: 2019 & 2030
Rising Middle Class Population Aids Growth
EXHIBIT 6: Global Middle Class Population (in Millions) by
Geographic Region: 2010, 2020E & 2030P
Rising Healthcare Expenditure: Opportunities in Store
EXHIBIT 7: World Healthcare Expenditure (In US$ Billion) for
the Years 2017-2023
EXHIBIT 8: Healthcare Costs as a % of GDP by Country for the
Years 2020 & 2023
Risk of CAD in Obesity Offers Prospects for Coronary Stenting
EXHIBIT 9: Obesity Prevalence Rate (%) in Select Countries for
the Years 2019 and 2030P
Diabetics at Higher Risk of Heart Diseases
EXHIBIT 10: Diabetes Prevalence Worldwide by Region: Number of
Adults (20-79 Years) with Diabetes in 2015 and 2040
The Hypertension-Cholesterol Link to Drive Demand
EXHIBIT 11: Hypertension Prevalence (%) Worldwide by Region in
Male and Females Aged 25+ Years
Metal Bioresorbable scaffolds Exhibit Improved Performance
Compared to Polymer Stents
Metal Stents Vis-à-Vis Other Stents

4. GLOBAL MARKET PERSPECTIVE
Table 1: World Current & Future Analysis for Bioresorbable
Stents by Geographic Region - Europe, Asia-Pacific and Rest of
World Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2020 through 2027 and % CAGR

Table 2: World 7-Year Perspective for Bioresorbable Stents by
Geographic Region - Percentage Breakdown of Value Sales for
Europe, Asia-Pacific and Rest of World Markets for Years 2020 &
2027

Table 3: World Current & Future Analysis for Polymer-based by
Geographic Region - Europe, Asia-Pacific and Rest of World
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2020 through 2027 and % CAGR

Table 4: World 7-Year Perspective for Polymer-based by
Geographic Region - Percentage Breakdown of Value Sales for
Europe, Asia-Pacific and Rest of World for Years 2020 & 2027

Table 5: World Current & Future Analysis for Metal-based by
Geographic Region - Europe, Asia-Pacific and Rest of World
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2020 through 2027 and % CAGR

Table 6: World 7-Year Perspective for Metal-based by Geographic
Region - Percentage Breakdown of Value Sales for Europe,
Asia-Pacific and Rest of World for Years 2020 & 2027

Table 7: World Current & Future Analysis for Coronary Artery
Disease/CAD by Geographic Region - Europe, Asia-Pacific and
Rest of World Markets - Independent Analysis of Annual Sales in
US$ Thousand for Years 2020 through 2027 and % CAGR

Table 8: World 7-Year Perspective for Coronary Artery
Disease/CAD by Geographic Region - Percentage Breakdown of
Value Sales for Europe, Asia-Pacific and Rest of World for
Years 2020 & 2027

Table 9: World Current & Future Analysis for Peripheral Artery
Disease/PAD by Geographic Region - Europe, Asia-Pacific and
Rest of World Markets - Independent Analysis of Annual Sales in
US$ Thousand for Years 2020 through 2027 and % CAGR

Table 10: World 7-Year Perspective for Peripheral Artery
Disease/PAD by Geographic Region - Percentage Breakdown of
Value Sales for Europe, Asia-Pacific and Rest of World for
Years 2020 & 2027

Table 11: World Current & Future Analysis for Hospitals by
Geographic Region - Europe, Asia-Pacific and Rest of World
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2020 through 2027 and % CAGR

Table 12: World 7-Year Perspective for Hospitals by Geographic
Region - Percentage Breakdown of Value Sales for Europe,
Asia-Pacific and Rest of World for Years 2020 & 2027

Table 13: World Current & Future Analysis for Cardiovascular
Centers by Geographic Region - Europe, Asia-Pacific and Rest of
World Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2020 through 2027 and % CAGR

Table 14: World 7-Year Perspective for Cardiovascular Centers
by Geographic Region - Percentage Breakdown of Value Sales for
Europe, Asia-Pacific and Rest of World for Years 2020 & 2027

III. MARKET ANALYSIS

EUROPE
Table 15: Europe Current & Future Analysis for Bioresorbable
Stents by Material - Polymer-based and Metal-based -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 16: Europe 7-Year Perspective for Bioresorbable Stents by
Material - Percentage Breakdown of Value Sales for
Polymer-based and Metal-based for the Years 2020 & 2027

Table 17: Europe Current & Future Analysis for Bioresorbable
Stents by Application - Coronary Artery Disease/CAD and
Peripheral Artery Disease/PAD - Independent Analysis of Annual
Sales in US$ Thousand for the Years 2020 through 2027 and %
CAGR

Table 18: Europe 7-Year Perspective for Bioresorbable Stents by
Application - Percentage Breakdown of Value Sales for Coronary
Artery Disease/CAD and Peripheral Artery Disease/PAD for the
Years 2020 & 2027

Table 19: Europe Current & Future Analysis for Bioresorbable
Stents by End-Use - Hospitals and Cardiovascular Centers -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 20: Europe 7-Year Perspective for Bioresorbable Stents by
End-Use - Percentage Breakdown of Value Sales for Hospitals and
Cardiovascular Centers for the Years 2020 & 2027

ASIA-PACIFIC
Table 21: Asia-Pacific Current & Future Analysis for
Bioresorbable Stents by Material - Polymer-based and
Metal-based - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 22: Asia-Pacific 7-Year Perspective for Bioresorbable
Stents by Material - Percentage Breakdown of Value Sales for
Polymer-based and Metal-based for the Years 2020 & 2027

Table 23: Asia-Pacific Current & Future Analysis for
Bioresorbable Stents by Application - Coronary Artery
Disease/CAD and Peripheral Artery Disease/PAD - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR

Table 24: Asia-Pacific 7-Year Perspective for Bioresorbable
Stents by Application - Percentage Breakdown of Value Sales for
Coronary Artery Disease/CAD and Peripheral Artery Disease/PAD
for the Years 2020 & 2027

Table 25: Asia-Pacific Current & Future Analysis for
Bioresorbable Stents by End-Use - Hospitals and Cardiovascular
Centers - Independent Analysis of Annual Sales in US$ Thousand
for the Years 2020 through 2027 and % CAGR

Table 26: Asia-Pacific 7-Year Perspective for Bioresorbable
Stents by End-Use - Percentage Breakdown of Value Sales for
Hospitals and Cardiovascular Centers for the Years 2020 & 2027

REST OF WORLD
Table 27: Rest of World Current & Future Analysis for
Bioresorbable Stents by Material - Polymer-based and
Metal-based - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 28: Rest of World 7-Year Perspective for Bioresorbable
Stents by Material - Percentage Breakdown of Value Sales for
Polymer-based and Metal-based for the Years 2020 & 2027

Table 29: Rest of World Current & Future Analysis for
Bioresorbable Stents by Application - Coronary Artery
Disease/CAD and Peripheral Artery Disease/PAD - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR

Table 30: Rest of World 7-Year Perspective for Bioresorbable
Stents by Application - Percentage Breakdown of Value Sales for
Coronary Artery Disease/CAD and Peripheral Artery Disease/PAD
for the Years 2020 & 2027

Table 31: Rest of World Current & Future Analysis for
Bioresorbable Stents by End-Use - Hospitals and Cardiovascular
Centers - Independent Analysis of Annual Sales in US$ Thousand
for the Years 2020 through 2027 and % CAGR

Table 32: Rest of World 7-Year Perspective for Bioresorbable
Stents by End-Use - Percentage Breakdown of Value Sales for
Hospitals and Cardiovascular Centers for the Years 2020 & 2027

IV. COMPETITION
Total Companies Profiled: 25
Read the full report: https://www.reportlinker.com/p05956093/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001


Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting